human
adenoviru
ad
use
extens
deriv
replicationincompet
gene
deliveri
vector
correct
genet
disord
develop
candid
vaccin
varieti
infecti
diseas
cancer
immunotherapi
condit
replic
ad
crad
agent
cancer
virotherapi
adenoviru
vector
use
gene
therapi
clinic
trial
follow
retrovir
vector
nakedplasmid
deoxyribonucl
acid
dna
major
factor
limit
effect
currentgener
ad
vector
inabl
accomplish
specif
gene
deliveri
cell
interest
inde
nation
institut
health
report
identifi
need
vector
target
central
object
field
gene
therapi
extens
studi
interact
ad
capsid
protein
host
cell
vitro
reveal
effici
ad
infect
requir
presenc
suffici
level
receptor
respons
viru
attach
cellular
membran
intern
adenoviru
attach
cell
mediat
fiber
bind
ctermin
knob
domain
primari
cellular
receptor
subsequ
interact
v
integrin
secondari
cellular
receptor
argglyasp
rgd
sequenc
within
protein
loop
extend
penton
base
requir
trigger
endocytosi
result
viru
intern
ad
speci
b
shown
use
human
membran
cofactor
predomin
attach
receptor
wherea
coxsackieviru
group
b
ad
receptor
car
identifi
primari
highaffin
receptor
mani
repres
speci
c
e
f
therefor
level
car
express
determin
infect
efficaci
ad
serotyp
speci
b
ad
serotyp
speci
c
respect
mostli
use
vector
construct
purpos
thu
unfavor
express
pattern
primari
ad
receptor
clinic
context
would
result
insuffici
level
infect
target
cell
lead
ectop
viru
sequestr
nontarget
tissu
delin
key
step
ad
cellular
entri
pathway
vitro
cell
attach
distinct
subsequ
viru
intern
suggest
ad
recognit
cognat
primari
receptor
repres
ratelimit
step
could
interven
effort
redirect
viruscel
bind
via
altern
cellular
receptor
confer
suscept
ad
vector
infect
transduct
target
strategi
seek
redirect
ad
bind
appropri
nonn
receptor
increas
effici
gene
transfer
cell
type
select
achiev
therapeut
intervent
effort
redirect
ad
vector
via
receptor
overexpress
cell
refractori
ad
infect
mainli
focu
incorpor
target
ligand
mean
chemic
conjug
genet
modif
viral
capsid
protein
use
bispecif
adapt
molecul
mediat
viru
recognit
target
cell
use
bispecif
protein
adapt
origin
propos
bridg
viral
particl
cell
surfac
molecul
overcom
ineffici
viru
infect
owe
scarciti
ad
attach
receptor
local
inaccess
part
cell
goal
origin
address
develop
bispecif
antibodi
bsab
conjug
abl
bind
viral
capsid
protein
cell
surfac
receptor
allow
indirect
linkag
viral
particl
cellular
receptor
figur
construct
bsab
adapt
wickham
et
al
use
monoclon
antibodi
mab
flag
peptid
genet
incorpor
place
delet
rgd
sequenc
penton
base
protein
chemic
conjug
mab
specif
v
integrin
receptor
human
redirect
adflag
vector
endotheli
smooth
muscl
cell
cell
respect
although
success
demonstr
feasibl
vitro
viru
retarget
via
nonad
receptor
display
human
venul
endotheli
cell
intestin
smooth
muscl
cell
rest
cell
normal
refractori
approach
later
abandon
appar
reduc
viru
viabil
result
rgd
sequenc
delet
altern
figur
strategi
ad
vector
target
use
bispecif
adapt
adenoviru
retarget
variou
cell
type
achiev
use
bispecif
adapt
protein
bispecif
adapt
consist
ad
fiber
knobbind
moieti
fuse
altern
receptorbind
ligand
includ
fab
antibodi
scfv
ab
biolog
ligand
target
adapt
allow
effici
carindepend
transduct
cell
interest
approach
provid
adapt
bind
ad
capsid
propos
dougla
et
al
base
use
neutral
mab
block
bind
fiber
knob
car
feasibl
ad
retarget
via
nonvir
receptor
demonstr
conjug
fab
fragment
mab
folat
allow
viru
linkag
folat
receptor
overexpress
surfac
varieti
malign
cell
fabfol
conjug
complex
vector
carri
luciferas
report
gene
shown
redirect
viru
infect
target
cell
via
folat
receptor
high
effici
complex
carri
gene
herp
simplex
viru
thymidin
kinas
fabfol
conjug
mediat
specif
kill
cell
overexpress
folat
receptor
work
demonstr
feasibl
employ
adapt
approach
ablat
endogen
viral
tropism
introduc
novel
tropism
vitro
use
abbas
vector
target
approach
explor
circumv
lack
car
express
improv
gene
transfer
specif
tumor
cell
gener
bispecif
ab
conjug
consist
antiknob
fab
fragment
conjug
mab
deriv
epiderm
growth
factor
receptor
egfr
tumorassoci
marker
neglig
express
normal
mitot
quiescent
tissu
target
vector
via
egfr
use
ab
conjug
led
enhanc
gene
transfer
rel
untarget
ad
human
glioma
cell
line
primari
glioma
sampl
deriv
tumor
variou
histolog
furthermor
egfr
retarget
show
mark
transduct
enhanc
squamou
cell
carcinoma
head
neck
cell
line
primari
tumor
tissu
compar
normal
tissu
patient
studi
illustr
ad
target
via
egfr
overcom
cell
defici
car
express
achiev
increas
gene
transfer
effici
tumor
cell
type
therefor
suggest
bispecif
adapt
approach
could
augment
ad
vector
potenc
cancer
gene
therapi
applic
base
essenti
find
adapt
approach
employ
promot
admedi
gene
transfer
dendrit
cell
dc
assess
target
util
context
import
therapeut
applic
propos
genet
modifi
dc
end
tillman
et
al
test
fab
fragment
chemic
conjug
mab
agonist
bind
dc
receptor
receptor
attract
dc
target
import
role
induc
dc
matur
prime
cytotox
cell
vector
retarget
via
pathway
use
bispecif
construct
dramat
enhanc
gene
transfer
monocytederiv
dc
modc
establish
peripher
blood
normal
human
volunt
donor
induc
phenotyp
function
matur
demonstr
increas
cell
stimul
allogen
mix
leukocyt
reaction
enhanc
interleukin
il
releas
explor
potenti
adaptermedi
target
approach
enhanc
efficaci
dcbase
vaccin
vivo
tillman
et
al
employ
similar
fab
conjug
mab
mous
along
ad
vector
encod
tumor
antigen
end
vector
express
human
papillomaviru
oncogen
repres
attract
target
antigenspecif
immun
cervic
cancer
coupl
fabantimurin
use
load
bone
marrowderiv
dc
bmdc
ex
vivo
shown
subcutan
inject
bmdc
infect
provid
superior
protect
tumor
challeng
improv
prophylaxi
outgrowth
establish
tumor
rel
bmdc
infect
untarget
ad
studi
illustr
admodifi
dc
may
use
repeat
vaccin
establish
antigenspecif
celldepend
protect
find
suggest
adbas
dc
load
tumor
antigen
elicit
product
antitumor
immun
enhanc
gene
transfer
dc
matur
mediat
ad
complex
may
facilit
process
demonstr
clinic
util
adaptermedi
dc
target
de
gruijl
et
al
evalu
ad
vector
perform
context
threedimension
human
tissu
physiolog
clinic
highli
relev
condit
end
human
skin
explant
model
use
test
transduct
effici
cutan
dc
intraderm
inject
vector
preincub
antiknob
conjug
significantli
enhanc
transduct
effici
select
increas
activ
state
migrat
dc
achiev
extend
antigenspecif
cytotox
lymphocyt
ctl
stimulatori
abil
week
start
migrat
contrast
dc
transduc
untarget
ad
dc
target
vivo
might
obviat
need
vitro
cultur
autolog
dc
adopt
transfer
ad
vector
constitut
promis
new
vaccin
modal
tumor
immunotherapi
determin
whether
adaptermedi
adtarget
approach
could
maintain
fidel
upon
system
vascular
administr
reynold
et
al
use
bispecif
ab
conjug
target
ad
infect
specif
angiotensinconvert
enzym
ace
preferenti
express
pulmonari
capillari
administr
acetarget
vector
complex
via
tail
vein
inject
rat
result
least
increas
ad
genom
local
luciferas
transgen
express
lung
wherea
luciferas
activ
liver
reduc
compar
untarget
vector
studi
show
adaptermedi
ad
target
inde
alter
biodistribut
profil
ad
vector
given
system
thu
provid
encourag
implic
develop
target
inject
ad
vector
may
enabl
gene
therapi
pulmonari
vascular
diseas
use
acetarget
adapt
combin
endothelialspecif
transgen
express
driven
promot
result
synergist
improv
select
luciferas
express
lung
versu
usual
site
vector
sequestr
liver
use
adaptermedi
ad
retarget
toward
tumor
cell
demonstr
use
mab
epitheli
cell
adhes
molecul
epcam
conjug
antifib
knob
fab
fragment
epcamtarget
ad
vector
complex
bispecif
ab
conjug
show
improv
transduct
primari
tumor
cell
cell
line
establish
gastric
esophag
adenocarcinoma
compar
normal
gastric
epithelium
use
similar
approach
chemic
conjug
antiknob
fab
achiev
basic
fibroblast
growth
factor
effort
develop
new
treatment
approach
kaposi
sarcoma
note
use
ad
complex
achiev
direct
therapeut
goal
murin
orthotop
model
human
ovarian
carcinoma
relev
current
human
clinic
cancer
gene
therapi
scheme
refin
adapt
approach
accomplish
engin
recombin
protein
consist
neutral
singlechain
fragment
variabl
scfv
ab
ad
fiber
knob
fuse
human
egf
scfv
egfr
improv
infect
effici
cancer
cell
recombin
adapt
molecul
advantag
ad
retarget
use
chemic
conjug
ab
molecul
increas
difficulti
produc
ad
retarget
complex
make
approach
rel
complex
expens
develop
improv
vector
target
specif
use
nativ
tropismabl
ad
previous
construct
contain
carand
v
integrinbind
mutat
residu
test
use
bispecif
scfv
adapt
target
toward
human
egfr
epcam
eleg
studi
van
beusechem
et
al
demonstr
nativ
tropismabl
ad
vector
complex
bispecif
scfv
effici
select
target
altern
receptor
surfac
human
cancer
cell
line
primari
human
tumor
specimen
moreov
egfrtarget
doubli
ablat
vector
select
human
brain
tumor
versu
surround
normal
brain
tissu
result
improv
tumortonorm
brain
target
index
compar
nonabl
control
vector
applic
epcamtarget
doubleabl
ad
vector
gastric
cancer
gene
therapi
show
favor
ration
tumor
normal
tissu
transduct
note
transduct
effici
mediat
epcamtarget
nativ
tropismabl
ad
complex
reach
level
similar
exceed
achiev
nativ
ad
control
epcamexpress
primari
human
gastric
tumor
wherea
transduct
gastric
epithelium
liver
tissu
reduc
least
achiev
target
genet
modif
hepat
stellat
cell
hsc
reetz
et
al
design
peptid
nerv
growth
factor
ngfp
specif
affin
neurotrophin
receptor
present
hsc
coupl
ngfp
ad
particl
done
via
chemic
conjug
use
bifunct
polyethylen
glycol
peg
coat
fusion
protein
compos
scfv
coupl
ngfp
ad
via
pegyl
result
markedli
reduc
liver
tropism
enhanc
gene
transfer
hsc
wherea
ad
transduc
activ
hsc
better
ad
gfppegngfp
studi
contribut
develop
gene
transfer
system
target
activ
hsc
base
system
appli
ad
vector
modifi
ngfp
success
exampl
employ
bispecif
adapt
achiev
receptorspecif
ad
gene
transfer
ration
develop
recombin
adapt
molecul
design
regard
dmitriev
et
al
propos
use
solubl
extracellular
car
domain
scar
fuse
human
egf
target
ligand
engin
novel
class
adapt
capabl
block
cardepend
ad
tropism
promot
infect
cardefici
cell
type
overexpress
egfr
includ
human
mammari
gland
ovarian
epidermoid
squamou
pancreat
carcinoma
cell
similar
approach
appli
engin
scar
ectodomain
fuse
fc
region
human
immunoglobulin
protein
target
ad
vector
via
highaffin
fc
receptor
achiev
increas
transgen
express
carneg
human
monocyt
cell
line
express
target
receptor
use
noninvas
optic
imag
monitor
firefli
luciferas
luc
luciferindepend
bioluminesc
activ
liang
et
al
show
system
vascular
administr
vector
coat
newli
gener
scaregf
protein
result
significantli
reduc
ectop
luc
express
liver
markedli
facilit
luc
express
tumor
xenograft
display
elev
egfr
level
compar
control
demonstr
liver
untarget
tumor
retarget
ad
vector
mediat
bispecif
recombin
adapt
suggest
scaregfco
virion
could
maintain
fidel
system
deliveri
thu
provid
encourag
implic
develop
target
inject
ad
vector
system
may
enabl
gene
therapi
cancer
assess
use
adapt
approach
ad
target
colon
lung
breast
epitheli
tumor
express
carcinoembryon
antigen
cea
li
et
al
use
noninvas
optic
imag
bioluminesc
luc
activ
provid
ad
complex
bispecif
scarmf
protein
contain
scfv
cea
use
scarmf
adapt
result
ad
vector
retarget
ceaposit
epitheli
tumor
cell
cell
cultur
subcutan
tumor
xenograft
hepat
tumor
graft
show
greater
reduct
addirect
luc
express
liver
system
vector
administr
use
recombin
adapt
molecul
elimin
chemic
conjug
provid
high
degre
flexibl
ligand
substitut
consequ
expand
target
capabl
ad
vector
consider
warrant
develop
adaptermedi
ad
target
approach
improv
potenc
context
system
applic
one
develop
endeavor
design
bispecif
recombin
molecul
higher
bind
affin
viral
capsid
maintain
fidel
virusadapt
complex
subsequ
system
deliveri
regard
structur
analysi
fiber
knob
bound
car
domain
identif
conserv
carbind
site
fiber
protein
suggest
avid
mechan
three
car
molecul
could
simultan
bind
per
one
fiber
knob
trimer
support
kinet
analysi
knob
bind
car
domain
base
consider
hypothes
trimer
scarligand
molecul
could
achiev
highaffin
linkag
fiber
knob
promot
ligandmedi
bind
target
receptor
test
hypothesi
kashentseva
et
al
engin
adapt
protein
consist
scar
phage
fibritinderiv
polypeptid
scfv
oncoprotein
confer
ad
target
capabl
cancer
cell
express
oncogen
demonstr
incorpor
fibritin
polypeptid
provid
trimer
scar
fusion
protein
result
increas
affin
ad
fiber
knob
augment
abil
block
cardepend
ad
infect
compar
monomer
scar
protein
illustr
cancer
cell
line
overexpress
target
ad
complex
adapt
protein
provid
enhanc
gene
transfer
compar
ad
alon
increas
compar
untarget
ad
complex
scarfibritin
control
protein
parallel
studi
kim
et
al
employ
isoleucin
trimer
domain
improv
scar
bind
fiber
knob
engin
recombin
adapt
contain
cyclic
rgd
peptid
crgd
receptorbind
domain
apolipoprotein
e
achiev
effici
gene
transfer
human
diploid
fibroblast
vitro
wherea
trimer
scar
devoid
target
ligand
provid
effici
block
ectop
liver
gene
transfer
normal
mice
addit
either
ligand
fail
retarget
liver
vivo
appli
gene
therapi
treatment
hepat
colorect
cancer
crc
metastat
tumor
often
express
cea
li
et
al
coupl
use
promot
transcript
control
transduct
target
mediat
trimer
scarfmf
adapt
contain
anticea
scfv
studi
demonstr
use
transcript
control
scarfmf
adapt
allow
retarget
admedi
express
herp
simplex
viru
type
thymidin
kinas
therapeut
gene
normal
liver
tissu
hepat
crc
tumor
system
viru
inject
increas
therapeut
efficaci
ganciclovir
treatment
hepat
crc
tumor
reduc
hepat
toxic
result
indic
trimer
scarligand
protein
markedli
improv
ad
target
potenc
vivo
owe
highaffin
bind
fiber
knob
effici
block
cardepend
viral
tropism
confer
novel
cellbind
specif
mediat
trimer
ligand
moieti
via
altern
tumorassoci
receptor
scarderiv
adapt
also
exploit
confer
ad
target
abil
toward
dendrit
cell
dc
orchestr
immun
respons
effort
develop
vaccin
potent
anticanc
immunotherapi
current
procedur
ex
vivo
load
autolog
dc
tumorassoci
antigen
taa
activ
clinic
applic
labori
expens
remain
poorli
standard
use
viral
vector
repres
attract
altern
approach
load
resid
dc
vivo
target
taa
deliveri
simultan
activ
feasibl
scarmedi
ad
target
dc
demonstr
pereboev
et
al
gener
scar
fusion
scfv
human
deriv
use
hybridoma
cell
line
demonstr
highli
effici
transduct
immatur
modc
use
adapt
asiedu
et
al
show
improv
transduct
matur
rhesu
monkey
modc
ad
express
transform
growth
factor
tgf
could
significantli
suppress
alloimmun
respons
inhibit
prolifer
respond
cell
result
work
clement
et
al
illustr
adaptermedi
ad
target
promot
gene
express
nonhuman
primat
matur
modc
function
alloantigenspecif
cellular
immunosuppress
approach
potenti
facilit
induct
allograft
toler
vivo
studi
brando
et
al
show
bispecif
scfv
adapt
serv
well
significantli
enhanc
ad
transduct
effici
human
modc
increas
abil
modc
activ
ctl
antigenspecif
manner
develop
approach
achiev
use
adapt
molecul
design
fuse
ectodomain
car
ligand
via
trimer
motif
incorpor
trimer
motif
serv
increas
fiber
knob
bind
avid
maintain
nativ
trimer
conform
necessari
effici
bind
function
compat
human
counterpart
owe
high
degre
homolog
mous
human
tumor
necrosi
factorlik
domain
pereboev
et
al
show
gene
transfer
mous
bmdc
use
ad
four
order
magnitud
effici
untarget
control
result
transduct
bmdc
compar
undetect
transduct
use
control
import
ad
induc
vivo
phenotyp
dc
matur
upregul
express
elicit
superior
th
ctl
respons
model
antigen
balbc
mice
result
studi
demonstr
admedi
gene
transfer
dc
significantli
enhanc
use
nonn
transduct
pathway
pathway
may
import
applic
genet
vaccin
cancer
infecti
diseas
studi
effect
adaptermedi
ad
target
via
pathway
vivo
huang
et
al
compar
biodistribut
immun
respons
intraven
iv
intraderm
id
intranas
administr
untarget
control
balbc
mice
inject
iv
reveal
increas
transgen
express
lung
thymu
normal
sequest
signific
amount
viru
system
administr
id
inject
ad
show
lower
gene
transfer
signal
detect
mainli
local
drain
lymph
node
skin
compar
control
note
undesir
ectop
sequestr
untarget
detect
brain
tissu
show
second
highest
gene
express
level
lung
larg
ablat
use
ad
complex
moreov
target
elicit
sustain
antigenspecif
cellular
immun
respons
nucleocapsid
protein
sarscov
use
model
antigen
later
time
point
day
boost
id
applic
also
significantli
hamper
humor
respons
irrespect
administr
rout
studi
demonstr
adaptermedi
ad
target
profoundli
alter
pattern
viru
biodistribut
immun
respons
transgen
local
system
administr
preclin
evid
therapeut
use
adaptermedi
dc
target
approach
cancer
immunotherapi
obtain
hangalapura
et
al
use
ad
encod
fulllength
melanoma
antigen
recogn
coupl
adapt
demonstr
enhanc
transduct
convent
plasmacytoid
dc
subset
b
cell
suspens
human
melanomadrain
sentinel
lymph
node
ex
vivo
result
reduct
regulatori
cell
treg
frequenc
facilit
expans
function
cell
studi
hangalapura
et
al
demonstr
enhanc
transduct
matur
cultur
bmdc
vector
encod
immunodomin
epitop
tyrosinaserel
protein
fuse
egfp
compar
untarget
control
bmdc
transduc
dctarget
vector
ex
vivo
induc
stronger
specif
tcell
respons
peripher
blood
result
improv
prophylact
vaccin
efficaci
aggress
poorli
immunogen
murin
melanoma
model
assess
effect
target
induct
immun
weakli
immunogen
taa
vector
encod
fulllength
human
employ
id
vaccin
studi
reveal
significantli
enhanc
induct
specif
cell
respons
antitumor
efficaci
prophylact
therapeut
vaccin
set
translat
improv
surviv
tumorbear
anim
receiv
vaccin
result
thu
clearli
show
enhanc
antitumor
efficaci
afford
vivo
target
vaccin
encod
weakli
immunogen
taa
dc
taken
togeth
studi
support
use
ad
vector
vivo
dc
target
accomplish
highefficaci
ctl
prime
break
immun
toler
taa
achiev
therapeut
anticanc
efficaci
preclin
clinic
studi
test
whether
strategi
improv
outcom
prostat
cancer
immunotherapi
william
et
al
develop
murin
model
prostat
cancer
gener
deriv
mous
prostat
cancer
cell
line
express
human
prostatespecif
membran
antigen
psma
maxim
antigen
present
target
cell
major
histocompat
complex
class
transport
associ
antigen
process
protein
express
induc
cell
transduct
vector
express
interferongamma
administ
dc
infect
ex
vivo
use
coupl
adapt
well
direct
intraperiton
inject
vectoradapt
complex
result
high
level
tumorspecif
ctl
respons
cell
pretreat
thu
significantli
improv
therapeut
antitumor
efficaci
data
suggest
dctarget
ad
deliveri
psma
mediat
adapt
may
effect
clinic
prostat
cancer
immunotherapi
adapt
approach
explor
improv
ad
vector
util
lymphocytebas
therapi
surmount
lymphocyt
resist
ad
infect
beatti
et
al
propos
design
scar
ectodomain
fusion
murin
interleukin
target
ad
murin
receptor
lymphocyt
specif
highli
express
therapeut
lymphocyt
popul
regulatori
lymphocyt
activ
lymphocyt
studi
show
use
vector
coupl
adapt
infect
murin
tcell
line
activ
primari
murin
lymphocyt
allow
nineand
fourfold
improv
report
gene
express
level
compar
vector
alon
respect
find
broad
applic
studi
cell
biolog
genet
modif
cell
therapeut
use
technolog
design
ankyrin
repeat
protein
darpin
ribosom
display
employ
develop
darpin
bind
fiber
knob
domain
low
nanomolar
affin
particular
dreier
et
al
report
novel
design
bispecif
adapt
protein
chelat
knob
bival
trival
fashion
provid
bind
specif
establish
cellsurfac
biomark
human
cancer
studi
show
efficaci
gene
transfer
adapterad
complex
increas
accordingli
function
affin
molecul
enabl
effici
viru
transduct
low
stoichiometr
adaptertofib
ratio
principl
darpin
gener
target
make
versatil
adapt
approach
use
develop
broad
rang
diseasespecif
ad
vector
applic
recent
refin
darpin
technolog
allow
develop
seri
adapt
bind
fiber
knob
high
affin
remain
fulli
bound
day
block
ad
nativ
receptor
tropism
mediat
interact
surfac
receptor
choic
solv
crystal
structur
complex
trimer
knob
three
bound
darpin
resolut
dreier
et
al
use
comput
model
devis
trimer
protein
extraordinari
kinet
stabil
specif
capsid
protein
shp
lambdoid
phage
serv
bind
knob
like
trimer
clamp
fuse
darpin
vari
specif
thu
allow
gene
transfer
egfr
epcamdepend
manner
transduct
effici
compar
even
exceed
alon
adapt
effici
produc
escherichia
coli
ad
confer
new
receptor
specif
use
receptorbind
ligand
avail
mani
cell
type
choic
suggest
mean
engin
practic
effect
ad
target
approach
achiev
strong
associ
viral
particl
adapt
protein
sever
group
propos
combin
genet
capsid
modif
target
adapt
approach
end
fiber
capsid
protein
genet
fuse
ctermin
biotin
acceptor
peptid
bap
adenoviru
particl
bear
bap
metabol
biotinyl
vector
product
endogen
biotin
ligas
cell
produc
coval
biotinyl
virion
result
biotinyl
vector
could
retarget
new
receptor
conjug
biotinyl
antibodi
use
tetramer
avidin
k
campo
et
al
use
panel
metabol
biotinyl
ad
vector
directli
compar
target
transduct
mediat
fiber
protein
ix
hexon
capsid
protein
use
varieti
biotinyl
ligand
includ
mab
transferrin
egf
cholera
toxin
b
studi
clearli
demonstr
effect
cell
target
could
achiev
biotinyl
fiber
protein
serv
receptorbind
ligand
conjug
contrast
protein
ix
hexonmedi
ligand
conjug
ligand
fail
provid
vector
target
like
aberr
traffick
cell
surfac
insid
target
cell
data
suggest
ad
target
like
effici
fiber
modif
rather
pix
hexon
protein
use
vector
contain
metabol
biotinyl
fiber
protein
chen
et
al
show
retarget
primari
cultur
human
corneal
epitheli
cell
mediat
conjug
biotinyl
egf
provid
ninefold
increas
transduct
egfrexpress
corneal
epitheli
progenitor
cell
reduc
transduct
differenti
corneal
epitheli
cell
biotinavidin
linkag
also
use
conjug
ad
vector
ligand
bind
high
affin
v
integrin
dcsign
receptor
improv
efficaci
human
modc
transduct
matur
abil
stimul
cytokin
product
autolog
memori
cell
vectorencod
immunodomin
human
cytomegaloviru
protein
compar
untarget
viru
studi
expand
rang
receptor
could
employ
dc
target
facilit
develop
adbas
vaccin
altern
target
strategi
propos
combin
genet
incorpor
immunoglobulin
ig
bind
domain
staphylococcu
aureu
protein
ad
fiber
protein
target
ligand
fuse
ig
fc
domain
form
vectorligand
target
complex
korokhov
et
al
show
target
ligand
contain
fc
domain
either
scfv
form
stabl
complex
ad
vector
incorpor
socal
cd
aureu
protein
result
signific
augment
gene
deliveri
modc
target
cell
use
similar
approach
genet
fiber
modif
insert
synthet
acid
iggbind
domain
deriv
protein
volper
et
al
demonstr
increas
gene
transfer
efficaci
differenti
primari
human
muscl
cell
achiev
preincub
vector
mab
direct
neuron
cell
adhes
molecul
integrin
versatil
ad
target
strategi
employ
kawashima
et
al
demonstr
highli
effici
gene
transfer
biliari
cancer
cell
use
vector
combin
mab
epcam
egfr
compar
control
antibodi
without
antibodi
studi
show
vector
construct
express
uracil
phosphoribosyl
transferas
complex
antiepcam
antiegfr
mab
remark
enhanc
sensit
biliari
cancer
cell
cell
lack
epcam
egfr
express
includ
normal
hepatocyt
thu
result
significantli
suppress
growth
biliari
cancer
xenograft
nude
mice
employ
versatil
iggbind
ad
vector
approach
hold
promis
solv
problem
structur
biosynthet
compat
viral
capsid
protein
target
ligand
allow
direct
use
avail
repertoir
mab
cell
surfac
antigen
ad
target
varieti
cellular
receptor
use
bispecif
adapt
approach
establish
sever
key
concept
respect
goal
ad
vector
retarget
clearli
shown
vector
provid
effect
gene
transfer
via
carindepend
cell
entri
pathway
thu
viru
interact
primari
attach
receptor
appear
essenti
attain
effect
cell
entri
achiev
carindepend
infect
via
altern
cellular
receptor
allow
augment
level
gene
transfer
inde
redirect
infect
via
nonvir
receptor
allow
improv
suscept
target
cell
vitro
vivo
target
use
adapt
molecul
depend
interact
viral
capsom
regard
target
abil
bispecif
molecul
appear
effici
ad
fiber
interact
rather
pix
hexon
protein
discuss
molecular
adapt
allow
modif
ad
tropism
key
proofofprincipl
demonstr
target
gene
transfer
vitro
vivo
deliveri
context
howev
genet
capsid
modif
approach
prefer
configur
clinic
applic
target
ad
vector
method
alter
ad
vector
tropism
capit
knowledg
viral
capsid
protein
includ
fiber
hexon
penton
base
pix
key
determin
specif
ad
infect
basi
consider
sever
approach
develop
alter
tropism
use
genet
capsid
modif
figur
first
instanc
method
ad
retarget
base
use
ad
capsid
pseudotyp
use
fiber
substitut
fiber
differ
serotyp
chimer
fiber
primarili
deriv
virus
employ
differ
receptor
cell
bind
includ
earli
studi
use
method
construct
vector
contain
chimer
fiber
compos
tail
shaft
domain
knob
domain
ad
serotyp
establish
recent
studi
demonstr
high
transduct
efficaci
vector
varieti
tumor
cell
type
low
car
express
includ
renal
cell
carcinoma
ovarian
cancer
melanoma
prostat
cancer
cell
sever
fiber
chimer
ad
vector
develop
achiev
tumoror
tissuespecif
gene
deliveri
employ
fiber
deriv
past
decad
addit
approach
ad
retarget
develop
use
fiber
nonhuman
ad
speci
number
fiberxenotyp
vector
develop
base
chimer
fiber
knob
domain
aviadenoviru
atadenoviru
canin
ad
serotyp
canin
ad
serotyp
porcin
ad
serotyp
addit
fiber
nonhuman
ad
vector
fibermosa
vector
encod
two
differ
fiber
includ
wildtyp
receptorbind
molecul
dear
reoviru
serotyp
construct
use
fiberlik
attach
protein
provid
enhanc
infect
tissu
low
car
express
tropism
expans
via
infect
cell
express
sialic
acid
junction
adhes
molecul
ad
target
must
embodi
concept
tumor
complex
tissu
compos
mani
interdepend
cellular
compon
includ
malign
cell
cancer
stem
stemlik
cell
tumorassoci
stromal
element
regard
fibermosa
strategi
capsid
modif
singl
viral
particl
incorpor
two
distinct
fiber
speci
evalu
use
mosaic
vector
fiber
deriv
wildtyp
fiber
protein
consist
aminotermin
segment
fiber
sequenc
genet
fuse
carboxytermin
portion
phage
fibritin
protein
follow
linker
ligand
anoth
studi
murakami
et
al
gener
fibermosa
ad
vector
display
fiber
chimer
fiber
protein
compos
tail
domain
shaft
knob
domain
capac
dualfib
ad
vector
transduc
distinct
cell
type
mix
cell
popul
demonstr
vitro
fiber
profil
allow
expand
tropism
requir
inclus
target
strategi
base
use
fibermosa
viral
particl
infect
cell
effici
distinct
receptor
repertoir
recent
studi
demonstr
employ
fiber
deriv
increas
oncolyt
potenc
crad
experiment
therapi
studi
use
human
pancreat
tumor
xenograft
model
demonstr
employ
complex
mosaic
increas
efficaci
combin
oncolyt
virotherapi
chemotherapi
sever
strategi
develop
alter
tropism
vector
achiev
cellspecif
gene
deliveri
employ
fiber
modif
use
genet
incorpor
target
motif
gener
retarget
strategi
focus
ad
fiber
modif
major
determin
ad
tropism
shown
insert
integrinbind
rgd
motif
polylysin
peptid
cterminu
fiber
knob
significantli
reduc
transduct
effici
carposit
cell
ad
vector
earli
studi
use
expos
hiloop
structur
connect
h
ad
knob
domain
altern
locat
cysteineconstrain
cdcrgdcfc
peptid
insert
demonstr
dmitriev
et
al
base
evid
rgd
polylysin
motif
bind
differ
cell
surfac
protein
cellular
integrin
heparan
sulfatecontain
receptor
respect
doublemodifi
ad
fiber
knob
rgd
motif
shown
enhanc
infect
via
carindepend
pathway
improv
gene
transfer
effici
promis
data
demonstr
studi
phage
display
techniqu
use
determin
specif
bind
peptid
display
polypeptid
repertoir
surfac
filament
phage
well
peptid
incorpor
ad
librari
shown
valuabl
method
isol
uniqu
peptid
employ
ad
target
vivo
select
phage
display
librari
ad
librari
display
random
peptid
fiber
knob
techniqu
success
employ
acquir
number
tumorhom
peptid
target
specif
relat
angiogen
blood
vessel
cdcrgdcfc
cngrcvsgcagrc
tumor
lymphat
vessel
cgnkrtrgc
pancreat
cancer
syenfsa
renal
cell
carcinoma
hitsll
phage
display
technolog
use
isol
hvggssv
peptid
bind
specif
taxinteract
receptor
irradi
tumor
although
modif
allow
tropism
alter
mani
instanc
applic
approach
limit
incompat
capsid
ligand
addit
target
motif
fuse
fiber
protein
demonstr
decreas
bind
function
impair
proper
protein
tertiari
structur
mean
transduct
retarget
ad
accomplish
fiber
modif
approach
allow
incorpor
larg
complex
target
moieti
retain
trimer
fiber
modif
base
concept
chimer
knobless
fiber
replac
nativ
ad
fiber
knob
protein
altern
protein
capabl
provid
trimer
function
allow
incorpor
target
peptid
initi
studi
involv
gener
knobless
ad
vector
trimer
motif
deriv
moloney
murin
leukemia
viru
bacteriophag
fibritin
trimer
motif
deriv
reovir
protein
introduc
place
knob
domain
follow
ctermin
mycepitop
fibermodifi
vector
shown
mediat
receptorspecif
transduct
vitro
interact
surfaceexpress
ab
wherea
wide
rang
target
moieti
employ
recombin
ad
vector
restrict
repertoir
avail
target
peptid
function
compat
insert
fiber
protein
led
consider
variou
ab
speci
ad
retarget
purpos
furthermor
biosynthesi
candid
ab
speci
design
ad
incorpor
must
compat
ad
capsid
protein
synthesi
assembl
point
avail
ab
speci
prove
biolog
compat
cytosol
ad
capsid
synthesi
assembl
result
loss
bind
affin
loss
bind
specif
instanc
incorpor
scfv
like
ad
capsid
protein
normal
synthes
cytosol
assembl
nucleu
wherea
scfv
molecul
typic
rout
rough
endoplasm
reticulum
context
redox
state
cytosol
like
result
improp
scfv
fold
perturb
structur
configur
requir
antigen
recognit
lead
loss
bind
specif
despit
demonstr
util
stabil
scfv
molecular
scaffold
motif
design
resist
deleteri
effect
cytosol
redox
state
ad
retarget
limit
avail
repertoir
target
specif
class
scfv
practic
restrict
approach
recent
studi
valid
use
fiberbas
target
moieti
use
synthet
construct
monobodi
repres
singledomain
ab
mimic
base
tenth
human
fibronectin
type
iii
domain
scaffold
achiev
select
gene
transfer
use
tropismmodifi
ad
contrast
synthet
construct
monobodi
kaliberov
et
al
consid
use
altern
antibodi
speci
might
embodi
stabil
profil
compat
cytosol
biosynthesi
ad
capsid
protein
discoveri
unconvent
immunoglobulin
deriv
serum
anim
camelid
famili
camel
alpaca
consist
two
heavychain
hcab
basi
antigen
recognit
bind
made
possibl
use
admedi
gene
therapi
unlik
convent
immunoglobulin
hcab
contain
singl
variabl
domain
vhh
link
two
constant
domain
clone
isol
singledomain
antibodi
shown
effect
target
model
system
remark
stabil
profil
compar
convent
immunoglobulin
scfv
shown
express
anticea
vhh
genet
incorpor
deknob
fiberfibritin
protein
disrupt
trimer
capabl
ad
fiber
retain
antigen
recognit
function
abil
anticea
vhh
fuse
fiberfibritin
chimera
provid
specif
effici
target
ceaexpress
cancer
cell
admedi
gene
transfer
also
demonstr
despit
demonstr
use
fiber
modif
ad
retarget
approach
limit
incompat
fiber
protein
ligand
lead
impair
antigen
recognit
function
anoth
approach
focus
develop
retarget
ad
use
capsid
protein
besid
fiber
earli
studi
small
peptid
incorpor
ad
capsid
protein
peptid
epitop
hemagglutinin
protein
influenza
viru
within
penton
base
evid
show
hexon
abund
ad
capsid
protein
make
hexon
attract
site
present
target
moieti
tendenc
iv
administ
local
liver
repres
major
factor
limit
current
strategi
accomplish
target
ad
vector
major
pathway
liver
transduct
involv
interact
ad
capsid
protein
circul
blood
cell
plasma
protein
includ
sever
compon
complement
pathway
blood
coagul
zymogen
although
univers
accept
liver
uptak
ad
mediat
highaffin
interact
major
protein
capsid
hexon
glutam
acid
domain
coagul
factor
x
fx
complex
attach
hepatocyt
bind
serin
proteas
domain
fx
cell
surfac
heparan
sulfat
proteoglycan
shown
differ
ad
serotyp
interact
fx
distinct
affin
instanc
human
ad
serotyp
bind
fx
rel
low
affin
compar
recent
shown
ablat
fx
bind
modifi
hexon
protein
result
decreas
liver
tropism
comparison
hexon
sequenc
among
differ
ad
serotyp
reveal
sever
uniqu
serotypespecif
sequenc
hypervari
region
loop
expos
exterior
surfac
hexon
molecul
incorpor
dcrgdcf
ligand
hexon
result
enhanc
transduct
cell
low
level
car
express
anoth
studi
epitop
incorpor
shown
hvr
amen
insert
motif
addit
ab
recogn
ad
vector
insert
hvr
subsequ
studi
demonstr
hexon
capabl
accommod
peptid
amino
acid
aa
length
well
bap
protein
minim
advers
effect
virion
stabil
later
shown
substitut
hexon
result
decreas
liver
tropism
dramat
alter
biodistribut
gene
express
system
administr
mice
produc
luc
express
liver
respect
lower
wildtyp
result
studi
suggest
combin
liver
detarget
use
genet
modif
hexon
endotheliumspecif
transcript
control
element
produc
addit
effect
improv
biodistribut
minor
capsid
protein
ix
pix
present
copi
ad
capsid
exploit
anchor
heterolog
ctermin
extens
aa
length
includ
spacer
pix
protein
peptid
ligand
myctaggedpix
molecul
readili
access
antimyc
ab
earli
studi
use
pix
genet
incorpor
target
ligand
establish
dmitriev
et
al
studi
ad
vector
contain
modifi
pix
carri
ctermin
flag
epitop
along
heparan
sulfat
bind
motif
consist
either
eight
consecut
lysin
polylysin
sequenc
construct
pix
variant
effici
incorpor
capsid
ad
particl
use
antiflag
ab
shown
modifi
pix
incorpor
virion
display
flagcontain
ctermin
sequenc
capsid
surfac
incorpor
polylysin
motif
pix
ectodomain
result
signific
augment
ad
fiber
knobindepend
infect
cardefici
cell
type
use
strategi
ad
retarget
achiev
incorpor
larg
target
moieti
includ
egfp
metallothionein
use
pix
protein
platform
present
scfv
sdab
molecul
ad
retarget
evalu
scfv
direct
select
capac
fold
correctli
reduc
environ
cytoplasm
fuse
pix
use
sequenc
anoth
studi
singlechain
cell
receptor
direct
cancertesti
antigen
melanomaassoci
antigen
mage
complex
human
leukocyt
antigen
hla
class
molecul
haplotyp
fuse
c
terminu
pix
gener
particl
specif
transduc
melanoma
cell
express
target
complex
least
higher
effici
control
virus
howev
natur
ad
capsid
protein
synthesi
virion
assembl
even
endoplasm
reticulumtarget
pixscfv
protein
incorpor
ad
capsid
low
level
suffici
retarget
viru
infect
contrast
shown
express
antiegfrviii
sdab
ad
capsid
fusion
pix
use
redirect
ad
infect
wide
acknowledg
improv
therapeut
potenti
ad
vector
requir
elimin
natur
viral
tropism
introduct
novel
mechan
select
cell
recognit
would
allow
direct
viru
local
target
tissu
strategi
describ
includ
use
bispecif
adapt
molecul
genet
incorpor
target
ligand
capsid
protein
extens
develop
redirect
infect
via
nonn
pathway
target
ad
vector
hold
promis
expand
type
diseas
treat
gene
therapi
make
therapeut
applic
ad
vector
effect
increas
specif
achiev
target
viru
infect
cell
interest
ultim
allow
lower
safer
dose
ad
vector
provid
region
system
deliveri
contempl
futur
natur
virushost
interact
dictat
fate
system
administ
ad
vector
come
consider
scrutini
recent
year
recent
studi
focus
biolog
interact
ad
capsid
compon
host
blood
factor
influenc
system
viru
biodistribut
reveal
abil
vitamin
kdepend
coagul
factor
vii
ix
x
protein
c
bind
trimer
hexon
viral
capsid
facilit
carindepend
infect
hepat
cell
intravascular
vector
administr
effort
serv
highlight
complex
virushost
interplay
artifici
bloodborn
environ
identifi
modif
fiber
hexon
protein
significantli
decreas
infect
virusinduc
toxic
liver
thu
recogn
infect
pathway
system
administ
mediat
via
multipl
mechan
involv
blood
factor
rather
direct
viru
interact
cellular
receptor
basi
becom
increasingli
appar
engin
capsid
protein
overcom
ectop
sequestr
liver
coupl
viru
retarget
via
nonn
infect
pathway
repres
ration
strategi
direct
ad
vector
local
tissu
interest
subsequ
system
vascular
administr
regard
genet
engin
ad
fiber
protein
appear
straightforward
way
gener
target
ad
vector
novel
tropism
despit
major
advanc
illustr
potenti
genet
ad
target
vitro
effort
employ
highaffin
ligand
includ
growth
factor
scfv
mostli
unsuccess
frustrat
target
ad
vector
mani
attract
cellular
marker
basi
deliber
use
altern
ab
speci
might
embodi
stabil
profil
compat
cytosol
biosynthesi
ad
capsid
protein
consid
camelid
hcab
possess
characterist
ideal
ad
retarget
strategi
cytosol
stabil
allow
function
incorpor
ad
capsid
compat
phage
biopan
select
allow
target
cell
specif
base
use
attribut
number
target
ad
vector
use
genet
incorpor
sdab
fiberfibritin
pix
protein
develop
find
provid
import
technic
approach
allow
practic
linkag
capsid
modif
ad
vector
ligandbas
strategi
target
gene
deliveri
wherea
singlecompon
vector
system
favor
employ
context
human
clinic
trial
rigor
analysi
pharmacodynam
system
stabil
vectoradapt
complex
could
provid
rational
clinic
translat
respect
previou
vivo
studi
use
variou
fiber
knobbind
adapt
provid
compel
evid
reduc
ectop
liver
transduct
receptorspecif
vector
deliveri
target
organ
tumor
util
adapt
molecul
construct
use
knob
scfv
scar
ectodomain
obvious
limit
carbind
ad
serotyp
provid
rational
develop
new
class
protein
adapt
capabl
ad
vector
target
virtu
bind
altern
capsid
epitop
use
serotypeindepend
target
modal
could
provid
technic
mean
test
abil
vector
deriv
repres
variou
ad
speci
local
tissu
interest
overcom
ectop
organ
sequestr
thu
novel
ad
tropism
modif
maneuv
embodi
concept
detarget
retarget
combin
element
genet
capsid
modif
adapterbas
approach
encourag
implic
develop
advanc
deliveri
vehicl
